Vestal Point Capital’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-350,000	Closed	-$52.3M	–	63
2024 Q1	$52.3M	Buy	350,000 +315,000	+900%	+$47.1M	4.33%	7
2023 Q4	$6.7M	Buy	+35,000	New	+$6.7M	0.71%	31